Delivery Order SPE2DB20D1109-SPE2DB24FP39J
Award Date
6/26/24
Potential Completion Date
6/27/24
Potential Value
$3.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,533,880 units of dextroamphetamine extended-release 10 mg capsules in 100-count bottles. The contract has a ceiling value of $4,123.42 and an ultimate completion date of March 12, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation....
The U.S. Defense Logistics Agency (DLA) awarded a $1,809.93 firm fixed-price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,564,464,709 units of 15 mg dextroamphetamine extended-release capsules. The contract has a performance period through May 2, 2024. This delivery order is part of Amerisourcebergen's broader $999,999,999.00 Indefinite Delivery Contract with DLA Troop Support Medical to provide a comprehensive range of...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 4,565,166,325 units of dextroamphetamine extended-release 15 mg capsules. The contract, valued at $3,735.04, has a completion date of July 17, 2024. AmerisourceBergen, a major pharmaceutical distributor, is providing these essential medications to support federal healthcare programs and services. This award is a part of a larger Indefinite Delivery Contract...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to supply 4,565,970,595 units of Dextroamphetamine Extended Release 15 mg capsules. The $1,135.04 firm fixed price award has a completion date of September 30, 2024 and was made on September 27, 2024. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at up...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation for the supply of dextroamphetamine extended-release 15 mg capsules in 100-count bottles. The $10,385.02 fixed-price contract has a completion date of September 13, 2024. Amerisourcebergen, a major pharmaceutical distributor, is supplying these prescription medications under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999, which...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,561,020,421 units of Dextroamphetamine Extended-Release 15 mg capsules. The $1,465.68 firm-fixed-price contract has a performance period through May 23, 2023. AmerisourceBergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which maintains a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 10mg dextroamphetamine sustained-release capsules. The contract has a firm fixed-price of $6,205.52 and a completion date of May 27, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides comprehensive global...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,566,148,126 units of dextroamphetamine extended-release 15 mg capsules. The $1,508.38 Firm Fixed Price contract runs from October 2022 to October 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,019,039 units of the prescription medication dextroamphetamine-amphetamine 15 mg capsules, with a ceiling value of $1,528.00. The contract has an ultimate completion date of April 24, 2025 and was awarded on April 23, 2025. It is a firm fixed-price, non-set-aside contract....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of dextroamphetamine extended-release 10 mg capsules in 90-count packages, with a total ceiling value of $2,457.09. The contract is a firm fixed-price delivery order, with an ultimate completion date of May 21, 2025. The contract is not designated as a set-aside. Amerisourcebergen...